ZEISS Medical Technology announced that the CLARUS 700 from ZEISS has received National Medical Products Administration (NMPA) approval in China, offering advanced retinal diagnostic capabilities with ultra-widefield, high-resolution images in True Color and unsurpassed quality. The fundus imaging device with Fluorescein Angiography helps eye care specialists in China unlock the full potential of their clinic's retina workflow to support improved patient vision preservation.
ZEISS CLARUS 700 Receives NMPA Approval in China
Published on 06/05/2025 at 21:35
Share
Share
© S&P Capital IQ - 2025